 10X Genomics Inc NASDAQ: TXG reported preliminary second-quarter revenue is expected to be 114.5 million, a decrease of 1 year-over-year, below the consensus of 127.7 million. The company sees Americas revenue of 70.9 million 8 YY, EMEA 25.6 million -11 YY,. 